Following the successful launch of the 2020 Global Summit, “Nanotechnology for a Sustainable Future”, we are excited to announce that 2022 brings the opportunity for further depth into UN SDG #3, with the 2022 N4SN Global Summit.
FEBRUARY 2022:
“Nanotechnology for a Healthier and Sustainable Future”
Check your local Time Zone for Day 1, “Digital Health and AI”
Check your Local Time Zone for Day 2, “Nanomedicine”
Gain insight into two topics as they relate to Nanotechnology applied to Health and Wellbeing: (Day 1) Digital Health and AI Diagnostics, and (Day 2) Nanomedicine.
By attending, you can expect to uncover the latest scientific discoveries in these priority areas, alongside the key industry developments, projected global demand trends, the key regulatory frameworks at play, and the relationship between these areas to the achievement of supporting the UNSDGs.

Day 1 Key Note Speakers

Day 1: AI & Digital Health
22nd Feb (UTC +) / 23rd Feb (UTC -)
Prof. Dean Ho,
“Harnessing Digital Medicine to Optimize Nanotherapeutics”
National University of Singapore (UTC+8)
Prof. Dean Ho is the Provost’s Chair Professor in the Departments of Biomedical Engineering and Pharmacology, Director of the N.1 Institute for Health, and Head of the Department of Biomedical Engineering at the National University of Singapore. He was previously a professor at UCLA, and associate professor in the Departments of Biomedical Engineering and Mechanical Engineering, and Full Member of the Robert H. Lurie Comprehensive Cancer Center at the Feinberg School of Medicine of Northwestern University, Illinois, United States. Prof. Ho’s research has covered emerging areas of nanomedicine and nanodiamond-based drug delivery. Prof. Ho and his colleagues were the first to develop nanodiamond platforms for cancer therapy and wound healing, among other areas. His work in this area was published as the Cover Article of the March 9 issue of the journal Science Translational Medicine. Prof. Ho is also known for his work in the areas of artificial intelligence (AI) and its application towards personalized and precision medicine. His team and colleagues pioneered the field of Augmented AI (CURATE.AI), which mediates model-free and mechanism-independent N-of-1 combination therapy and rapidly accelerated and globally optimized drug development. This has led to multiple clinical trials that have validated the CURATE.AI platform.
Day 1 Key Note Speakers

Day 1: AI & Digital Health
22nd Feb (UTC +) / 23rd Feb (UTC -)
Dr. Kishor Wasan
“The Use of Artificial Intelligence and Machine Learning in the Discovery and Development of Novel Therapeutics for Emerging Infectious Diseases”
University of Saskatchewan, Canada (UTC+8)
Dr. Kishor Wasan is a Distinguished University Scholar Adj. Professor in the Department of Urologic Sciences, Faculty of Medicine at the University of British Columbia and Co-Founder of the Neglected Global Diseases Initiative-UBC. In addition, Dr. Wasan is the Chief Medical and Scientific Officer at Skymount Medical and was the former Dean and Professor (Retired) at the University of Saskatchewan. Dr. Wasan has published over 530 peer-reviewed papers, patents and conference proceedings in the area of Lipid-Based Drug Delivery, Lipoprotein and Cholesterol Metabolism and Infectious Diseases. He has won numerous awards and fellowships (over 25) and recently completed his Public Leadership Credential from the Harvard Kennedy School in 2021. You can learn more about Dr. Wasan by checking out his
LinkedIn page.
Day 2 Key Note Speakers

Day 2: Nanomedicine
23rd Feb (UTC +) / 24th Feb (UTC -)
Prof. Teri Odom
“Shape Effects and Designer Nanoconstructs for Nanomedicine”
North-western University, Chicago (UTC-6)
Prof. Teri Odom is the Director of The Odom Group, North-western University, which focuses on “making precious metals more precious” by controlling the size and shape of noble metals at the nanoscale. Prof. Teri Odom is also Chair of the Chemistry Department, Charles E. and Emma H. Morrison Professor of Chemistry, and a Professor of Materials Science and Engineering at Northwestern University. Prof. Odom is also the Associate Director International Institute for Nanotechnology (IIN), and affiliated with the the Chemistry of Life Processes Institute (CLP), Northwestern Initiative for Manufacturing Science and Innovation (NIMSI), Interdisciplinary Biological Sciences Graduate Program (IBiS), and the Department of Applied Physics at Northwestern University. Teri Odom is Editor-in-Chief of the journal of Nano Letters and Executive Editor of the journal ACS Photonics. She earned her bachelor’s degree in chemistry from Stanford University, her doctorate in chemical physics from Harvard University, and was a post-doctoral researcher at Harvard

Day 2: Nanomedicine
23rd Feb (UTC +) / 24th Feb (UTC -)
Prof. Christine Allen
“Harnessing Automation and Machine Learning for Sustainable Drug Formulation Development”
University of Toronto, Toronto (UTC-5)
Prof. Christine Allen is the Associate Vice-President and Vice-Provost, Strategic Initiatives at the University of Toronto and a full professor in the Leslie Dan Faculty of Pharmacy. She is the CEO and Scientific Director of the Nanomedicines Innovation Network, a National Centre of Excellence funded by the Government of Canada. Her research focuses on the design of innovative materials and drug delivery technologies with over 150 publications in this area. She is the co-founder and served as President of Nanovista Inc., a company focused on high-precision, image-guided cancer therapy. Professor Allen is a fellow of the American Institute for Medical and Biological Engineering, the Controlled Release Society (CRS) and the Canadian Academy of Health Sciences. She is the Editor-in-Chief of the Journal of Controlled Release, the President-Elect of the CRS and an appointed member of the Governing Council of the Natural Sciences and Engineering Research Council of Canada.
Day 1 Panel Discussion Speakers

Moderator:
Rohinton P. Medhora, President, Centre for International Governance Innovation (CIGI),Rohinton sits on The Lancet and the Financial Times Commission on Governing Health Futures 2030, as well as the Commission on Global Economic Transformation, co-chaired by Nobel economics laureates Michael Spence and Joseph Stiglitz. He serves on the boards of the Institute for New Economic Thinking and the McLuhan Foundation and is on the advisory boards of the WTO Chairs Programme, UNU-MERIT, and Global Health Centre. Rohinton is also Chair of the Ontario Workplace Recovery Advisory Committee. (full bio)
Panel Members:
Dean Ho, Director, Director, N.1 Institute for Health; Provost’s Chair Professor, Departments of Biomedical Engineering and Pharmacology; and Head of the Department of Biomedical Engineering (bio)
Kishor Wasan, Chief Medical & Scientific Officer, Skymount Medical US; Distinguished University Scholar Adj. Professor & Co-Director/Co-Founder , NGDI-UBC , Faculty of Medicine, University of British Columbia; PLC Harvard Kennedy Sch. (bio)
Mohammad Kohandel, Ass. Prof. and head of the Mathematical Medicine Laboratory at the Department of Applied Mathematics, University of Waterloo; Co-founder / CEO of MATHONCO BIOTECH INC (bio)
Day 2 Panel Discussion Speakers

Moderator:
Steffi Friedrichs, Director, AcumenIST, leading expert, policy advisor and business representative for emerging technological innovation for over 20 years. Founder and Director-General of the Nanotechnology Industries Association (NIA). She was a Co-Founder and Member of the Board of Directors of the Chicago Micro- & Nanotechnology Community (CMNC), Director of the Master’s Program in Micro- and Nanotechnology at the University of Cambridge, and Lecturer in Inorganic Chemistry and Solid State Chemistry at the University of Oxford. (full bio)
Panel Members:
Teri Odom, The Odom Group, North-western University; Chair, Department of Chemistry North-western University; Ass. Director, of International Institute for Nanotechnology at Northwestern University, Editor-in-Chief, Nano Letters, Executive Editor, ACS Photonics (full bio)
Christine Allen, Associate Vice-President and Vice-Provost, Strategic Initiatives at the University of Toronto; Professor in the Leslie Dan Faculty of Pharmacy.; CEO / Scientific Director of the Nanomedicines Innovation Network, a National Centre of Excellence funded by the Government of Canada; Co-founder of Nanovista Inc.,; Editor-in-Chief of Controlled Release, the President-Elect of the CRS and an appointed member of the Governing Council of the Natural Sciences and Engineering Research Council of Canada (full bio).
Samuel Chigome, Nanomaterials at Botswana Institute for Technology Research and Innovation – BITRI, with a focus on electrospun nanofiber based analytical device fabrication with applications in energy, health and the environment (full bio).
Dror Fixler, Director of the Bar-Ilan institute of nanotechnology and advanced materials; Professor of Electrical engineering and Nanophotonics at Bar-Ilan University in Ramat Gan, Israel. He is also a visiting professor in Technical Institute of Physics and Chemistry, China and member of the Nano Photonics Center at the Institute of Nanotechnology and Advanced Materials (BINA), and a Lecturer at the Faculty of Engineering (full bio).
Global Summit Steering Committee